Pharmaceutical
Healthcare
Technology

Novo Nordisk

920

$65.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-0.41%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Novo Nordisk and other stocks, options, ETFs, and crypto commission-free!

About NVO

Novo-Nordisk A/S, also called Novo Nordisk, is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. Read More The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

CEO
Lars Fruergaard Jørgensen
Employees
43,258
Headquarters
Bagsværd, Capital Region
Founded
1925
Market Cap
117.95B
Price-Earnings Ratio
25.59
Dividend Yield
1.35
Average Volume
1.31M
High Today
$66.19
Low Today
$65.17
Open Price
$65.92
Volume
879.40K
52 Week High
$68.72
52 Week Low
$47.25

Collections

Pharmaceutical
Healthcare
Technology
Health
Advertising and Marketing
Therapy
Business Services
Europe (Non-UK)

NVO Earnings

$0.00
$0.25
$0.51
$0.76
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Aug 6, Pre-Market

You May Also Like

PDLI
BFIN
FEN
FBIOP
PHAS
CMG
GDL
BANC-D
DUC
HD
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NVO

Market Price$65.61
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Novo Nordisk stock and options commission-free.
LearnBlogCareersHelpLog InSign Up